Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Misses Revenue Estimates

• click to rate

  Posted by Two Blokes 7 hours ago - Filed in Stock - 3 views
  
  Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to loss of $1.80 per share a year ago.